AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/393
PROGNOSTIC VALUE OF CONGESTIVE-HEART-FAILURE HISTORY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS
Authors: ANDERSON RD OHMAN EM HOLMES DR HARRINGTON RA BARSNESS GW WILDERMANN NM PHILLIPS HR TOPOL EJ CALIFF RM
Citation: Rd. Anderson et al., PROGNOSTIC VALUE OF CONGESTIVE-HEART-FAILURE HISTORY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS, Journal of the American College of Cardiology, 32(4), 1998, pp. 936-941
ATENOLOL USE AND CLINICAL OUTCOMES AFTER THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION - THE GUSTO-I EXPERIENCE
Authors: PFISTERER M COX JL GRANGER CB BRENER SJ NAYLOR CD CALIFF RM VANDEWERF F STEBBINS AL LEE KL TOPOL EJ ARMSTRONG PW
Citation: M. Pfisterer et al., ATENOLOL USE AND CLINICAL OUTCOMES AFTER THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION - THE GUSTO-I EXPERIENCE, Journal of the American College of Cardiology, 32(3), 1998, pp. 634-640
CLINICAL PREDICTORS OF EARLY INFARCT-RELATED ARTERY PATENCY FOLLOWINGTHROMBOLYTIC THERAPY - IMPORTANCE OF BODY-WEIGHT, SMOKING HISTORY, INFARCT-RELATED ARTERY AND CHOICE OF THROMBOLYTIC REGIMEN - THE GUSTO-I EXPERIENCE
Authors: LUNDERGAN CF REINER JS MCCARTHY WF COYNE KS CALIFF RM ROSS AM
Citation: Cf. Lundergan et al., CLINICAL PREDICTORS OF EARLY INFARCT-RELATED ARTERY PATENCY FOLLOWINGTHROMBOLYTIC THERAPY - IMPORTANCE OF BODY-WEIGHT, SMOKING HISTORY, INFARCT-RELATED ARTERY AND CHOICE OF THROMBOLYTIC REGIMEN - THE GUSTO-I EXPERIENCE, Journal of the American College of Cardiology, 32(3), 1998, pp. 641-647
OCCURRENCE AND CLINICAL-SIGNIFICANCE OF THROMBOCYTOPENIA IN A POPULATION UNDERGOING HIGH-RISK PERCUTANEOUS CORONARY REVASCULARIZATION
Authors: BERKOWITZ SD SANE DC SIGMON KN SHAVENDER JH HARRINGTON RA TCHENG JE TOPOL EJ CALIFF RM
Citation: Sd. Berkowitz et al., OCCURRENCE AND CLINICAL-SIGNIFICANCE OF THROMBOCYTOPENIA IN A POPULATION UNDERGOING HIGH-RISK PERCUTANEOUS CORONARY REVASCULARIZATION, Journal of the American College of Cardiology, 32(2), 1998, pp. 311-319
RANDOMIZED COMPARISON OF DIRECT THROMBIN INHIBITION VERSUS HEPARIN INCONJUNCTION WITH FIBRINOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION- RESULTS FROM THE GUSTO-IIB TRIAL
Authors: METZ BK WHITE HD GRANGER CB SIMES RJ ARMSTRONG PW HIRSH J FUSTER V MACAULAY CM CALIFF RM TOPOL EJ
Citation: Bk. Metz et al., RANDOMIZED COMPARISON OF DIRECT THROMBIN INHIBITION VERSUS HEPARIN INCONJUNCTION WITH FIBRINOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION- RESULTS FROM THE GUSTO-IIB TRIAL, Journal of the American College of Cardiology, 31(7), 1998, pp. 1493-1498
MODIFIABLE RISK-FACTORS FOR VASCULAR ACCESS SITE COMPLICATIONS IN THEIMPACT-II TRIAL OF ANGIOPLASTY WITH VERSUS WITHOUT EPTIFIBATIDE
Authors: MANDAK JS BLANKENSHIP JC GARDNER LH BERKOWITZ SD AGUIRRE FV SIGMON KN TIMMIS GC GILCHRIST IC MCIVOR M RESAR J WEINER BH GEORGE BS TALLEY JD LINCOFF AM TCHENG JE CALIFF RM TOPOL EJ
Citation: Js. Mandak et al., MODIFIABLE RISK-FACTORS FOR VASCULAR ACCESS SITE COMPLICATIONS IN THEIMPACT-II TRIAL OF ANGIOPLASTY WITH VERSUS WITHOUT EPTIFIBATIDE, Journal of the American College of Cardiology, 31(7), 1998, pp. 1518-1524
PROGNOSTIC-SIGNIFICANCE OF ST SEGMENT SHIFT EARLY AFTER RESOLUTION OFST ELEVATION IN PATIENTS WITH MYOCARDIAL-INFARCTION TREATED WITH THROMBOLYTIC THERAPY - THE GUSTO-I ST SEGMENT MONITORING SUBSTUDY
Authors: LANGER A KRUCOFF MW KLOOTWIJK P SIMOONS ML GRANGER CB BARR A CALIFF RM ARMSTRONG PW
Citation: A. Langer et al., PROGNOSTIC-SIGNIFICANCE OF ST SEGMENT SHIFT EARLY AFTER RESOLUTION OFST ELEVATION IN PATIENTS WITH MYOCARDIAL-INFARCTION TREATED WITH THROMBOLYTIC THERAPY - THE GUSTO-I ST SEGMENT MONITORING SUBSTUDY, Journal of the American College of Cardiology, 31(4), 1998, pp. 783-789
THROMBIN GENERATION, INHIBITION AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION TREATED WITH THROMBOLYTIC THERAPY AND HEPARIN - RESULTS FROM THE GUSTO-I TRIAL
Authors: GRANGER CB BECKER R TRACY RP CALIFF RM TOPOL EJ PIEPER KS ROSS AM ROTH S LAMBREW C BOVILL EG
Citation: Cb. Granger et al., THROMBIN GENERATION, INHIBITION AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION TREATED WITH THROMBOLYTIC THERAPY AND HEPARIN - RESULTS FROM THE GUSTO-I TRIAL, Journal of the American College of Cardiology, 31(3), 1998, pp. 497-505
ABCIXIMAB ASSOCIATED THROMBOCYTOPENIA - EVIDENCE FOR A COMPLEX INTERACTION WITH HEPARIN
Authors: KEREIAKES DJ BERKOWITZ SD ANDERSON K SIMOONS M VAHANIAN A LINCOFF AM TCHENG JE WEISMAN H CALIFF RM TOPOL EJ
Citation: Dj. Kereiakes et al., ABCIXIMAB ASSOCIATED THROMBOCYTOPENIA - EVIDENCE FOR A COMPLEX INTERACTION WITH HEPARIN, Journal of the American College of Cardiology, 31(2), 1998, pp. 55-55
HEPARIN DOSING AND OUTCOME IN ACUTE CORONARY SYNDROMES - THE GUSTO-IIB EXPERIENCE
Authors: GILCHRIST IC GRANGER CB THOMPSON TD CALIFF RM
Citation: Ic. Gilchrist et al., HEPARIN DOSING AND OUTCOME IN ACUTE CORONARY SYNDROMES - THE GUSTO-IIB EXPERIENCE, Journal of the American College of Cardiology, 31(2), 1998, pp. 78-78
HIRUDIN REDUCES DEATH AND MYOCARDIAL (RE)INFARCTION AT 6-MONTHS - FOLLOW-UP RESULTS OF THE GUSTO IIB TRIAL
Authors: GRANGER CB VANDEWERF F ARMSTRONG PW SIMES J WHITE H MACAULAY CM CALIFF RM TOPOL EJ
Citation: Cb. Granger et al., HIRUDIN REDUCES DEATH AND MYOCARDIAL (RE)INFARCTION AT 6-MONTHS - FOLLOW-UP RESULTS OF THE GUSTO IIB TRIAL, Journal of the American College of Cardiology, 31(2), 1998, pp. 79-79
FAILURE TO ACHIEVE OPTIMAL ANTICOAGULATION WITH COMMONLY USED HEPARINREGIMENS - A REVIEW OF GUSTO-II
Authors: WALI A HOCHMAN JS BERKOWITZ S CLARK KA MALHOTRA S CALIFF RM GRANGER C
Citation: A. Wali et al., FAILURE TO ACHIEVE OPTIMAL ANTICOAGULATION WITH COMMONLY USED HEPARINREGIMENS - A REVIEW OF GUSTO-II, Journal of the American College of Cardiology, 31(2), 1998, pp. 79-79
THROMBOCYTOPENIA IN A LARGE, INTERNATIONAL TRIAL OF THE GP IIB IIIA INHIBITOR EPTIFIBATIDE IN PATIENTS WITH ACUTE CORONARY SYNDROMES/
Authors: MCCLURE M KLEIMAN NS BERDAN LG SPARAPANI R TOPOL EJ DIAZ R CALIFF RM GRETLER D KARSCH KR HARRINGTON RA
Citation: M. Mcclure et al., THROMBOCYTOPENIA IN A LARGE, INTERNATIONAL TRIAL OF THE GP IIB IIIA INHIBITOR EPTIFIBATIDE IN PATIENTS WITH ACUTE CORONARY SYNDROMES/, Journal of the American College of Cardiology, 31(2), 1998, pp. 93-93
PRIOR ASPIRIN USE POTENTIATES THE EFFECT OF GP IIB IIIA INHIBITION INPATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES/
Authors: ALEXANDER JH HARRINGTON RA GUERCI A WEATHERLEY BD KARSCH KR CALIFF RM TOPOL EJ LINCOFF AM ARMSTRONG PW
Citation: Jh. Alexander et al., PRIOR ASPIRIN USE POTENTIATES THE EFFECT OF GP IIB IIIA INHIBITION INPATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES/, Journal of the American College of Cardiology, 31(2), 1998, pp. 93-93
EVIDENCE FOR AN ADVERSE INTERACTION BETWEEN ACE-INHIBITORS AND ASPIRIN FOLLOWING MYOCARDIAL-INFARCTION - THE GUSTO-I TRIAL
Authors: PETERSON JG LAUER MS YOUNG JB SAPP S CALIFF RM TOPOL EJ
Citation: Jg. Peterson et al., EVIDENCE FOR AN ADVERSE INTERACTION BETWEEN ACE-INHIBITORS AND ASPIRIN FOLLOWING MYOCARDIAL-INFARCTION - THE GUSTO-I TRIAL, Journal of the American College of Cardiology, 31(2), 1998, pp. 96-96
LACK OF PROGRESS IN CARDIOGENIC-SHOCK - LESSONS FROM THE GUSTO TRIALS
Authors: MENON V HOCHMAN JS HOLMES DR BATES ER ANDERSON RD CALIFF RM TOPOL EJ MAGNUS E
Citation: V. Menon et al., LACK OF PROGRESS IN CARDIOGENIC-SHOCK - LESSONS FROM THE GUSTO TRIALS, Journal of the American College of Cardiology, 31(2), 1998, pp. 136-136
DISAGREEMENT BETWEEN SITE INVESTIGATORS AND CLINICAL EVENT COMMITTEESIS COMMON AND CAN AFFECT TRIAL RESULTS
Authors: MAHAFFEY KW TARDIFF BE GRANGER CB LEE KL HARRINGTON RA TOPOL EJ CALIFF RM
Citation: Kw. Mahaffey et al., DISAGREEMENT BETWEEN SITE INVESTIGATORS AND CLINICAL EVENT COMMITTEESIS COMMON AND CAN AFFECT TRIAL RESULTS, Journal of the American College of Cardiology, 31(2), 1998, pp. 184-185
CLINICAL EFFICACY OF INTEGRILIN IN UNSTABLE ANGINA IS ACCOMPANIED BY A MODEST INCREASE IN HEMORRHAGIC RISK - THE PURSUIT TRIAL
Authors: LINCOFF AM HARRINGTON RA CALIFF RM BERDAN LG KITT MM WEATHERLY BD KLEIMAN NS TOPOL EJ
Citation: Am. Lincoff et al., CLINICAL EFFICACY OF INTEGRILIN IN UNSTABLE ANGINA IS ACCOMPANIED BY A MODEST INCREASE IN HEMORRHAGIC RISK - THE PURSUIT TRIAL, Journal of the American College of Cardiology, 31(2), 1998, pp. 185-185
SURVIVAL BENEFIT OF ABCIXIMAB ADMINISTRATION DURING EARLY RESCUE ANGIOPLASTY - ANALYSIS OF 387 PATIENTS FROM THE GUSTO-III TRIAL
Authors: MILLER JM OHMAN EM SCHILDCROUT JS SMALLING RW BETRIU A CALIFF RM TOPOL EJ
Citation: Jm. Miller et al., SURVIVAL BENEFIT OF ABCIXIMAB ADMINISTRATION DURING EARLY RESCUE ANGIOPLASTY - ANALYSIS OF 387 PATIENTS FROM THE GUSTO-III TRIAL, Journal of the American College of Cardiology, 31(2), 1998, pp. 191-191
LATE DIVERGING EVENT CURVES FOR SURVIVAL FOLLOWING IIB IIIA ANTAGONISM IN PATIENTS WITH UNSTABLE ANGINA - PARAGON STUDY 1-YEAR FOLLOW-UP/
Authors: MOLITERNO DJ HARRINGTON RA NEWBY KL ARMSTRONG PW VANDEWERF F WHITE HD CALIFF RM TOPOL EJ
Citation: Dj. Moliterno et al., LATE DIVERGING EVENT CURVES FOR SURVIVAL FOLLOWING IIB IIIA ANTAGONISM IN PATIENTS WITH UNSTABLE ANGINA - PARAGON STUDY 1-YEAR FOLLOW-UP/, Journal of the American College of Cardiology, 31(2), 1998, pp. 208-209
CLINICAL-RESULTS AND REVASCULARIZATION STATUS 5 YEARS FOLLOWING RANDOMIZATION TO PTCA OR CABG IN BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION (BARI)
Authors: ALDERMAN EL BOURASSA MG WHITLOW PL CALIFF RM SCHWARTZ L KIP KE
Citation: El. Alderman et al., CLINICAL-RESULTS AND REVASCULARIZATION STATUS 5 YEARS FOLLOWING RANDOMIZATION TO PTCA OR CABG IN BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION (BARI), Journal of the American College of Cardiology, 31(2), 1998, pp. 214-214
CLINICAL CHARACTERISTICS AND LONG-TERM OUTCOMES OF PATIENTS WITH DIASTOLIC HEART-FAILURE
Authors: OCONNOR CM SHAW LK WHELLAN DJ DELCARLO CH LARSEN RL GATTIS WA CUFFE MS CALIFF RM
Citation: Cm. Oconnor et al., CLINICAL CHARACTERISTICS AND LONG-TERM OUTCOMES OF PATIENTS WITH DIASTOLIC HEART-FAILURE, Journal of the American College of Cardiology, 31(2), 1998, pp. 218-218
A COMPARISON OF STATIC SERIAL VS CONTINUOUS ST-SEGMENT RECOVERY TO PREDICT OUTCOME AFTER LYTICS FOR MI
Authors: KRUCOFF MW GREEN CL TROLLINGER KM GRANGER CB OHMAN EM OCONNOR CM HARRINGTON RA ARMSTRONG PW SIMOONS ML TOPOL EJ CALIFF RM
Citation: Mw. Krucoff et al., A COMPARISON OF STATIC SERIAL VS CONTINUOUS ST-SEGMENT RECOVERY TO PREDICT OUTCOME AFTER LYTICS FOR MI, Journal of the American College of Cardiology, 31(2), 1998, pp. 228-229
REGIONAL VARIATION IN OUTCOMES AS DETERMINED BY INVESTIGATORS AND CLINICAL EVENTS COMMITTEE IN AN INTERNATIONAL TRIAL OF EPTIFIBATIDE IN NON-ST SEGMENT ELEVATION ACUTE CORONARY SYNDROMES
Authors: DECKERS JW HARRINGTON RA LINCOFF AM TOPOL EJ CALIFF RM BERDAN LG WEATHERLY BD WILCOX RG ARMSTRONG PW KITT MM SIMOONS ML
Citation: Jw. Deckers et al., REGIONAL VARIATION IN OUTCOMES AS DETERMINED BY INVESTIGATORS AND CLINICAL EVENTS COMMITTEE IN AN INTERNATIONAL TRIAL OF EPTIFIBATIDE IN NON-ST SEGMENT ELEVATION ACUTE CORONARY SYNDROMES, Journal of the American College of Cardiology, 31(2), 1998, pp. 309-309
RESOLUTION OF ST-SEGMENT ELEVATION 90 MINUTES AFTER THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION PREDICTS OUTCOME - A GUSTO-III SUBSTUDY
Authors: ANDERSON RD WHITE HD OHMAN EM WAGNER GS KRUCOFF MW ARMSTRONG PW IPARRAGUIRRE HP WEAVER WW GIBLER WB CALIFF RM
Citation: Rd. Anderson et al., RESOLUTION OF ST-SEGMENT ELEVATION 90 MINUTES AFTER THROMBOLYSIS FOR ACUTE MYOCARDIAL-INFARCTION PREDICTS OUTCOME - A GUSTO-III SUBSTUDY, Journal of the American College of Cardiology, 31(2), 1998, pp. 371-371
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>